Detalles de la búsqueda
1.
Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML.
Blood
; 123(4): 554-61, 2014 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24311721
2.
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
Blood
; 113(16): 3673-8, 2009 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-19015393
3.
A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer.
Clin Cancer Res
; 12(23): 7039-45, 2006 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17145826
4.
Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.
J Clin Oncol
; 23(3): 474-81, 2005 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15659493
5.
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.
J Clin Oncol
; 23(18): 4110-6, 2005 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15961759
6.
A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer.
Clin Cancer Res
; 11(10): 3854-61, 2005 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15897586
7.
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
J Clin Oncol
; 21(7): 1278-84, 2003 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12663715
8.
Oblimersen sodium (Genasense bcl-2 antisense oligonucleotide): a rational therapeutic to enhance apoptosis in therapy of lung cancer.
Clin Cancer Res
; 10(12 Pt 2): 4245s-4248s, 2004 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15217967
9.
The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk.
PLoS One
; 10(8): e0135945, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26305211
10.
Oblimersen sodium (G3139 Bcl-2 antisense oligonucleotide) therapy in Waldenstrom's macroglobulinemia: a targeted approach to enhance apoptosis.
Semin Oncol
; 30(2): 300-4, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12720157
11.
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Semin Oncol
; 30(2): 121-6, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12720120
12.
Targeting T cells to tumor cells using bispecific antibodies.
Curr Opin Chem Biol
; 17(3): 385-92, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23623807
13.
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.
Leuk Lymphoma
; 53(8): 1501-8, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22239668
14.
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.
Invest New Drugs
; 26(1): 81-7, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17960324
15.
Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma.
Cancer Res
; 68(10): 3785-94, 2008 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18483262
16.
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.
Blood
; 111(3): 1060-6, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17962510
17.
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
J Clin Oncol
; 25(21): 3109-15, 2007 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17577020
18.
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.
Blood
; 109(10): 4164-7, 2007 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17264295
19.
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).
Blood
; 109(1): 31-9, 2007 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16960145
20.
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
Biol Blood Marrow Transplant
; 12(2): 204-16, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16443518